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Abstract
Two voltage gated sodium channel α-subunits, Nav1.7 and Nav1.8, are expressed at high levels in
nociceptor terminals and have been implicated in the development of inflammatory pain. Mis-
expression of voltage-gated sodium channels by damaged sensory neurons has also been implicated
in the development of neuropathic pain, but the role of Nav1.7 and Nav1.8 is uncertain. Here we
show that deleting Nav1.7 has no effect on the development of neuropathic pain. Double knockouts
of both Nav1.7 and Nav1.8 also develop normal levels of neuropathic pain, despite a lack of
inflammatory pain symptoms and altered mechanical and thermal acute pain thresholds. These
studies demonstrate that, in contrast to the highly significant role for Nav1.7 in determining
inflammatory pain thresholds, the development of neuropathic pain does not require the presence
of either Nav1.7 or Nav1.8 alone or in combination.
Background
Voltage gated sodium channels (VGSC) underlie the elec-
trical excitability of nerve and muscle. VGSCs consist of
pore forming α-subunits and auxiliary β-subunits. There
are ten cloned α-subunits and 4 β-subunits. The β-subu-
nits modulate the localisation, expression and functional
properties of α-subunits [1]. Different α-subunits have
distinct electrophysiological and pharmacological proper-
ties [2]. The complex pattern of expression of α-subunits
may imply special roles for particular subunits in different
cell types [3]. Many loss- as well as gain-of-function muta-
tions of α-subunits have been identified in human condi-
tions characterised with epilepsy, seizures, ataxia and
increased sensitivity to pain. This suggests that mutations
of VGSC in humans are significant factors in aetiology of
neuronal diseases [4].
Nociceptors are a subset of sensory neurons that respond
to noxious thermal, mechanical and chemical stimuli.
Nociceptors express multiple subtypes of α-subunits [3].
Tissue and nerve damage leads to changes in expression
and function of α-subunits that in turn can lead to change
in the excitability of sensory neurons. Changes in the
excitability of sensory neurons are thought to underlie
some chronic pain conditions [5,6]. Nav1.8 and Nav1.7
are two α-subunits that are abundant in nociceptive sen-
sory neurons [3,7,8]. Nav1.8 is expressed exclusively in
sensory neurons and is not found in the CNS [9]. Func-
tional characterization of Nav1.8 positive neurons
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revealed that more than 85% are nociceptors [8]. Nav1.7
is expressed principally in peripheral neurons with very
weak expression detected in CNS [10,11]. As there are no
subunit specific blockers, gene knockouts in mice have
provided insights into the role of individual α-subunits
genes in pain [5]. Deletion of the Nav1.8 gene [12] and
nociceptor-specific knockout of the Nav1.7 [13] gene have
identified a role for these two α-subunits in setting
mechanical and, to a lesser extent, thermal pain thresh-
olds. In addition, behavioral studies have revealed deficits
in inflammatory pain models, most dramatically in the
nociceptor-specific Nav1.7 knockout [12,13]. These find-
ings suggest that these α-subunits could be targets for new
anti-inflammatory drugs.
Peripheral nerve injury leads to lowered pain thresholds,
enhanced responsiveness and/or ectopic activity in sen-
sory neurons that ultimately leads to hyperalgesia and
allodynia [5,6]. Changes in expression of α-subunits of
VGSCs have been documented in models of peripheral
nerve injury [5,6]. This has lead to the hypothesis that
modulation of α-subunits in sensory neurons may under-
lie the increased neuronal excitability of sensory neurons
following peripheral nerve injury. Pharmacological block-
ade of sodium channel activity has been shown to attenu-
ate ectopic activity [14,15] and reverse hyperalgesia
following nerve injury [16]. While the role of Nav1.7 in
neuropathic pain remains to be investigated, analysis of a
Nav1.8 knockout mouse indicated that it is not involved
in alteration of pain threshold following peripheral nerve
injury [17]. This is in contrast to the finding of Lai et al
who reported that antisense oligonucleotides directed
against Nav1.8 administered intrathecally completely
reverse neuropathic pain behavior [18]. It is possible that
this discrepancy could be due to the up-regulation of the
Nav1.7 channel seen in the Nav1.8 knockout mouse [12]
which might mask an otherwise important role for Nav1.8
in neuropathic pain.
In the present study we investigated the role of the Nav1.7
channel in neuropathic pain using nociceptor-specific
deletion of Nav1.7 in mouse. In addition, we readdressed
the role of Nav1.8 in neuropathic pain by generating a
double knockout of Nav1.8 and Nav1.7. We reasoned that
the co-deletion of Nav1.7 in Nav1.8-expressing neurons
should reveal any potential role for Nav1.8 in neuropathic
pain.
Results
Generation of Nav1.7 and Nav1.8 double knockouts in 
nociceptors
Nociceptor-specific Nav1.7 knockout mice and their litter-
mate controls were generated as described previously
[13]. It is not possible to generate global knockouts of
both Nav1.8 and Nav1.7 since global deletion of Nav1.7 is
lethal at P0 [13]. Therefore, we generated Nav1.7 and
Nav1.8 double-knockout (DKO) mice by exploiting the
fact that the Nav1.8Cre allele has Cre sequence inserted in
exon 1 followed by transcriptional stop signals [19]. Con-
sequently homozygous Nav1.8Cre mice are Nav1.8 global-
knockouts (Nav18 KO) and show no Nav1.8 currents in
sensory neurons [19].
We compared the DKO strain to the Nav1.8 KO
(homozygous Nav1.8Cre). To obtain the desired strains
we mated mice homozygous for the Nav1.8Cre/hetero-
zygous for floxed Nav1.7 allele with each other. The result-
ing progeny are all Nav1.8 Knockout. However, 25% will
have wildtype Nav1.7 alleles, 50% will be heterozygous
for the floxed Nav1.7 allele and 25% will be homozygous
for the floxed Nav1.7 allele (i.e. DKO) figure 1.
Eight weeks old C57BL6 inbred mice were used as
wildtype (WT) control (wildtype Nav1.8 and Nav1.7)
because it would be impractical and undesirable to gener-
ate them as littermates to the test groups (DKO and
Nav1.8 KO). The expected ratio of each of desired strains
would be only 6.25% if the parents were heterozygous for
both Nav1.8Cre and floxed Nav1.7 alleles compared with
Generation and genotyping of Nav1.7 and Nav1.8 double  knockout mice Figure 1
Generation and genotyping of Nav1.7 and Nav1.8 
double knockout mice. PCR genotyping of mice gener-
ated by breeding homozygous Nav1.8Cre/heterozygous 
floxed Nav1.7 mice with each other (lanes 2, 3, and 4). All 
the three groups are Nav1.8 Knockouts, i.e. positive for the 
Cre band (249 bp) and negative for the wildtype Nav1.8 band 
(460 bp). Mice homozygous for the floxed Nav1.7 allele (461 
vs. 317 bp band) are nociceptor-specific Nav1.7 knockout as 
well (lane 4). C57BL6 wildtype control is shown in lane 1 and 
no DNA negative control is in lane 5.
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25% as in our breeding strategy. The Nav1.8 KO/Nav1.7
heterozygous group was analysed in behavioural tests and
was found to be similar to the Nav1.8 KO group (data not
shown).
Development and motor coordination
The weight of male (WT 26.72 ± 1.60 gram, n = 6; Nav1.8
KO 23.44 ± 0.76, n = 9 and DKO 27.05 ± 1.63, n = 9) and
female (WT 20.50 ± 1.77 gram, n = 3; Nav1.8 KO 21.43 ±
0.95, n= 3 and DKO 19.66 ± 1.03, n = 4) mice in each
group was very similar and was not significantly different,
figure 2a. Motor coordination as tested through perform-
ance on the rotarod apparatus was unchanged between
the mouse groups studied. The time spent on the rotarod
was not significantly different between the three mouse
groups, figure 2b (WT 145.6 ± 13.12 sec, n = 4; Nav1.8 KO
146.4 ± 11.37, n = 7 and DKO 108.6 ± 11.5, n = 7).
Acute pain thresholds
We measured thermal pain thresholds using the hotplate
and Hargreave's tests. In the hotplate test, which involves
supraspinal activity, the response latency was not different
between the three mouse groups (WT 36.1 ± 6.5 sec, n =
7; Nav1.8 KO 29.0 ± 5.6, n = 7 and DKO 32.7 ± 6.35, n =
7), figure 3a. However, the response latency in the Har-
greave's test was doubled in DKO group (15.30 ± 0.91 sec,
n = 7) compared to both WT (6.88 ± 0.28, n = 11) and
Nav1.8 KO (8.47 ± 0.78, n = 7) groups, figure 3b. The
latency in the Nav1.8 KO was higher that that of the WT
group which is in agreement with the finding of Akopian
Development and motor coordination Figure 2
Development and motor coordination. A) Males and females mice have similar weights among the three groups being 
compared. In males the P value for WT vs. Nav1.8 KO is 0.09, for WT vs. DKO is 0.89 and for Nav1.8 KO vs. DKO is 0.08. In 
females the P value for WT vs. Nav1.8 KO is 0.27, for WT vs. DKO is 0.71 and for Nav1.8 KO vs. DKO is 0.27. B) Perform-
ance on the rotarod apparatus is not significantly different between the three mice groups. The P value for WT vs. Nav1.8 KO 
is 0.98, for WT vs. DKO is 0.38 and for Nav1.8 KO vs. DKO is 0.39. P values were calculated using two-tailed T-test. WT in 
white, Nav1.8 KO in grey and DKO in black.
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Acute pain thresholds are increased in the DKO mice Figure 3
Acute pain thresholds are increased in the DKO mice. A) Latency to respond in the hotplate test was not different 
between all groups. The P value for WT vs. Nav1.8 KO is 0.67, for WT vs. DKO is 0.72 and for Nav1.8 KO vs. DKO is 0.43. 
B) Latency to paw withdrawal in the Hargreave's test was doubled in the DKO mice. The P value for WT vs. Nav1.8 KO is 
0.08, for WT vs. DKO is <0.0001 and for Nav1.8 KO vs. DKO is <0.0001. C) The 50% withdrawal threshold to stimulation 
with von Frey hairs was not different between all groups. The P value for WT vs. Nav1.8 KO is 0.21, for WT vs. DKO is 0.25 
and for Nav1.8 KO vs. DKO is 0.84. D) The Nav1.8 KO and DKO mice showed profound analgesia to noxious mechanical 
pressure applied to the tail using the Randall-Selitto apparatus. The P value for WT vs. Nav1.8 KO is <0.0001, for WT vs. DKO 
is <0.0001 and for Nav1.8 KO vs. DKO is 0.67. P values were calculated using two-tailed T-test. WT in white, Nav1.8 KO in 
grey and DKO in black.
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et al using the conventional Nav1.8 global knockout [12].
The nociceptor-specific Nav1.7 knockout alone shows a
40% increase in latency in the Hargreave's test [13]
Pain thresholds to punctate mechanical stimulation was
measured using calibrated von Frey hairs according to the
up and down method [20]. The 50% withdrawal thresh-
old was not different between the three groups (WT 0.56
± 0.07 gram, n = 11; Nav1.8 KO 0.45 ± 0.05, n = 13 and
DKO 0.49 ± 0.06, n = 17), figure 3c. In contrast pain
threshold to noxious mechanical pressure applied to the
tail using the Randall-Selitto apparatus was much higher
in both the Nav1.8 KO (412.4 ± 33.97 gram, n = 7) and
DKO (395.7 ± 21.03, n = 7) groups compared to that of
the WT (131.4 ± 16.54, n = 6) group, figure 3d. Usually
the cut off point (500 gram) was reached without an
observed escape response in the Nav1.8 KO and DKO
groups, indicating a high resistance to static blunt
mechanical pressure. There was no difference between the
Nav1.8 and the DKO mice in this test, figure 3d, and sim-
ilar results have been obtained with the nociceptor-spe-
cific Nav1.7 knockout [13]
Inflammatory pain behaviour
The pain response elicited by injection of 20µl of 5% for-
malin intradermally in the hindpaw showed the typical
biphasic response in the three groups, figure 4a. The first
phase (1–10 minutes) was not different between the three
groups (WT 107.8 ± 10.12 sec n = 8, Nav1.8 KO 155 ±
11.00 n = 4, DKO 120.4 ± 5.96 n = 8), figure 4b. In con-
trast, the second phase (10–60 minutes) was much
reduced in the DKO group (105.4 ± 28.43 sec) compared
to both the Nav1.8 KO (309 ± 80.85, P = 0.08) and the WT
(216 ± 43.67, P = 0.0016) groups, figure 4b. This effect
was even more dramatic than that observed in the nocice-
ptor specific Nav1.7 knockout [13] We did not study other
inflammatory pain models since the nociceptor-specific
Nav1.7 knockout mouse is completely deficient in
Reduced pain behavior in formalin test in DKO Figure 4
Reduced pain behavior in formalin test in DKO. A) The pain response after injection of 5% formalin in hindpaw showed 
the typical biphasic course. B) The second phase of the formalin response was reduced to 30% in the DKO mice compared to 
WT and Nav1.8 KO mice. The P value for WT vs. Nav1.8 KO is 0.94, for WT vs. DKO is 0.001 and for Nav1.8 KO vs. DKO 
is 0.08. The first phase was not significantly different between all groups. The P value for WT vs. Nav1.8 KO is 0.60, for WT vs. 
DKO is 0.30 and for Nav1.8 KO vs. DKO is 0.96. P values were calculated using two-tailed T-test. WT in open circles, Nav1.8 
KO in grey triangles and DKO in black squares.
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commonly used inflammatory pain models [13]. It would
be impossible therefore to measure a further reduction in
inflammatory pain behaviour in the DKO.
Neuropathic pain in nociceptor-specific Nav1.7 knockout 
mice
To study neuropathic pain behavior we induced periph-
eral nerve injury using to the Chung model (ligation of L5
spinal nerve) in the Nav1.7 nociceptor-specific knockout
and homozygous floxed-Nav1.7 as controls. Both groups
developed a robust mechanical allodynia starting form
the third day post surgery, figure 5a. The extent and time
course of development of increased mechanosensitivity
was identical in both nociceptor-specific Nav1.7 knock-
out and their littermate controls.
Analysis of neuropathic pain in nociceptor-specific Nav1.7 knockout mice and double knockout mice Figure 5
Analysis of neuropathic pain in nociceptor-specific Nav1.7 knockout mice and double knockout mice. (A) Both 
control (white circles, mean 0.56 ± 0.9, n = 8) and nociceptor-specific Nav1.7 KO (black squares, 0.48 ± 0.8, n = 11) developed 
robust mechanical allodynia after ligation of spinal nerve L5. There is no difference in the extent of pain behavior at any time 
point (P = 0.49 ANOVA). (B) WT (open circles), Nav1.8 KO (grey triangles) and DKO (black squares) developed profound 
mechanical allodynia after ligation of spinal nerve L5.
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Neuropathic pain in Nav1.7 Nav1.8 double knockout mice
To address the issue of compensatory up-regulation of
Nav1.7 in Nav1.8 knockout we induced peripheral nerve
injury in WT, Nav1.8 KO and DKO. All mice groups
studied developed a robust mechanical allodynia starting
form the third day post surgery, figure 5b. There were no
statistically meaningful differences in the behaviour of the
groups of mice.
Discussion
This study confirms that the two sodium channel α- sub-
units Nav1.7 and Nav1.8, expressed selectively in nocicep-
tive sensory neurons, have important roles in nociception
and in pain. In the absence of specific pharmacological
blockers, the use of genetic approaches, a combination of
global and nociceptor-specific knockouts, has enabled us
to carry out studies exploring the contribution of these
two isoforms of VGSCs in different pain conditions.
Nav1.8 knockouts are already known to have deficits in
inflammatory and visceral but not neuropathic pain [12].
Nav1.7 nociceptor-specific knockouts are almost totally
refractory to changes in peripheral pain thresholds evoked
by inflammatory mediator [13]. This mirrors the inflam-
matory phenotype of Nav1.7 gain-of-function mutations
in erythermalgia [21]. This heritable disorder is caused by
point mutations that lead to altered thresholds of activa-
tion in Nav1.7 [22]
Acute pain thresholds
analysis of acute mechanical thresholds in DKO mice con-
firmed previous findings that the knockout of either
Nav1.8 or Nav1.7 renders the mice resistant in the Randel-
Selitto test of noxious mechanical pressure while the
responses to von Frey hairs remain unchanged compared
to controls [12,13]. Furthermore, it has been shown that
both Nav1.8 and nociceptor-specific Nav1.7 knockouts
have small increases of about 20–40% in their thermal
threshold [12,13]. Interestingly, we found that the ther-
mal threshold in the Hargreave's test was doubled in the
DKO compared to Nav1.8 knockout or WT controls, figure
3b. The increase is more than the sum of the phenotype in
the individual knockouts and may indicate that Nav1.8
and Nav1.7 are the major VGSC isoforms present in noci-
ceptive terminals and their deletion dramatically increases
pain threshold. This is supported by the fact that Nav1.7 is
transported to nerve terminals of sensory neurons [10]
and that Nav1.8 currents are localized in the terminals
[23].
Inflammatory pain
We have not studied pain behavior in inflammatory mod-
els where the nociceptive-specific Nav1.7 knockout has
shown complete deficits in inflammatory pain behavior
[13], because it would not be possible to observe further
changes brought about by the co-deletion of Nav1.8. We
only investigated the pain response in the formalin
model. While the nociceptive-specific Nav1.7 knockout
showed a reduction in the second phase to about 50% of
controls [13] the DKO showed a slightly bigger reduction
to 30% of controls, figure 4b. This is in contrast to Nav1.8
mice that showed no reduction in the second phase com-
pared to controls, figure 4b. Therefore, the reduction in
the second phase in the DKO is a new phenotype rather
than a mere summation of the phenotype in the individ-
ual knockouts. This highlights further the predominant
role for Nav1.7 in inflammatory pain. Expression of
Nav1.7 has been reported to increase in sensory neurons
subsequent to induction of inflammation [24].
This study and our previous [13] work have explored the
role of Nav1.7 in Nav1.8-expressing neurons, since our
strategy exploits the Nav1.8 promoter to drive Cre expres-
sion. We have shown previously using non-quantitative
RT-PCR that not all the Nav1.7 mRNA in DRGs from the
nociceptor-specific Nav1.7 knockout is deleted [13]. This
indicates that there is a population of sensory neurons,
the size of which has yet to be determined, that express
Nav1.7 but not Nav1.8. Therefore, the role of Nav1.7 in
sensory neurons where Nav1.8 is not expressed (and
which do not express Cre) remains to be studied.
From all the above, our results indicate that Nav1.8 and
Nav1.7 subunits contribute to the excitability of periph-
eral nerve terminals and their modulation is critical for
peripheral sensitisation in inflammatory pain
Neuropathic pain
We investigated the role of Nav1.7 expressed in nocicep-
tors in neuropathic pain. Analysis of neuropathic pain in
the nociceptor-specific Nav1.7 knockout using the Chung
model showed that they developed mechanical allodynia
to the same extent as the littermate control mice
(homozygous floxed Nav1.7), figure 5. This clearly shows
that unlike its critical role in inflammatory pain [13],
Nav1.7 does not contribute to neuropathic pain.
In addition, the Nav1.8 knockout and WT as well as the
DKO mice developed a profound mechanical allodynia
the level of which was indistinguishable between the three
groups. This provides further evidence that Nav1.8 does
not contribute to mechanical allodynia as reported by
Kerr et al [17]. In addition our results rule out Nav1.7 up-
regulation in the Nav1.8 knockout as the reason behind
the discrepancy between the finding of Kerr et al [17] and
Lai et al [18]. Surprisingly Lai et al [18] failed to detect the
changes in acute pain thresholds observed in the Nav1.8
KO both in this study and that of Akopian et al [12],
which would be expected to occur if Nav1.8 had been
down-regulated.Molecular Pain 2005, 1:24 http://www.molecularpain.com/content/1/1/24
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The lack of changes in mechanical allodynia in any indi-
vidual or even in double knockouts of Nav1.8 and Nav1.7
subunits is consistent with recent data by Flake et al. They
reported that changes in sodium currents shortly after
nerve injury do not correlate with an increase in neuronal
excitability and that the sum of changes to ionic currents,
and not a single class of voltage-gated ion channel, under-
lie increased neuronal excitability [25]. This does not,
however, exclude a potential role for both Nav1.7 and
Nav1.8 in spontaneous neuropathic pain as suggested by
the finding that neuromas in the Nav1.8 knockout mouse
display less ectopic discharges than wildtype littermates
[26]. These studies confirm the importance of Nav1.7 and
Nav1.8 in the physiological processes that underlie altered
peripheral thresholds in inflammatory pain. Neuropathic
pain that arises as a consequence of nerve damage and
neuronal dysfunction is, however, not dependent on the
presence of these two sodium channels. In terms of the
contribution of other α-subunits to neuropathic pain, a
strong correlation has been found between the expression
of Nav1.3 and the appearance of neuropathic pain. GDNF
that reverses neuropathic pain behaviour also normalises
Nav1.3 expression [27], and recent antisense studies have
supported the view that increased Nav1.3 expression con-
tributes to neuropathic pain development [28]
Conclusion
In summary, our results indicate a critical role for Nav1.7
and Nav1.8 in setting pain thresholds of nociceptive nerve
terminals and in their sensitisation following tissue dam-
age and inflammation. However, the presence of these
channels, or changes to their expression and function are
not required for the establishment of mechanical allody-
nia arising from nerve injury.
Methods
Genotyping of mice strains
Nav1.8Cre and floxed Nav1.7 lines were produced as
described [13]. Both strains were back-crossed at last 5
times onto a C57/BL6 background.
Genomic DNA was prepared from tail biopsies and geno-
typed using PCR. Primers for Nav1.7 are (CAGAGATTTCT-
GCATTAGAATTTGTTC) and
(AGTCTTTGTGGCACACGTTACCTC) which give a WT
band of 317 bp and a floxed band of 461 bp. Primers for
Nav1.8 are (TGTAGATGGACTGCAGAGGATGGA) and
(ttacccggtgtgtgctgtagaaag) which give a WT band of 460
bp. Nav1.8Cre was detected by primers (aaatttgcctgcattac-
cggtcga) and (aaatgttgctggatagtttttactgcc) located inside
Cre sequence which give a band of 249 bp.
Behavioural analysis
All tests were approved by the United Kingdom Home
Office Animals (Scientific Procedures) Act 1986 and per-
formed in a Home Office designated room at 22 ± 2°C.
Experiments were performed on animals of at least 8
weeks of age. Behavioral tests were done as before [19]
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